Targeting nicotinamide adenosine dinucleotide (NAD) in diffuse gliomas
Neuro Oncol
.
2022 Feb 1;24(2):245-246.
doi: 10.1093/neuonc/noab265.
Author
Jing Wu
1
Affiliation
1
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
PMID:
34919142
PMCID:
PMC8804876
DOI:
10.1093/neuonc/noab265
No abstract available
Publication types
Editorial
Research Support, N.I.H., Intramural
Comment
MeSH terms
Adenosine
Glioma* / drug therapy
Humans
NAD*
Niacinamide
Substances
NAD
Niacinamide
Adenosine